Monoallelic deletion of the p53 gene through chromosomal translocation in a small cell osteosarcoma

Virchows Archiv

Volumn 448, Issue 6, 2006, Pages 852-856

  Nishio, Jun ^a   Gentry, John D ^a   Neff, James R ^a   Nelson, Marilu ^b   Daniels, Wayne ^c   Perry, Deborah ^a,b   Gatalica, Zoran ^c   Bridge, Julia A ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytogenetics; FISH; p53; Small cell osteosarcoma

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN DEPENDENT KINASE 4; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MYC PROTEIN; PROTEIN MDM2; PROTEIN P53;

ANAMNESIS; ARTICLE; BONE RADIOGRAPHY; CANCER ADJUVANT THERAPY; CANCER SURGERY; CASE REPORT; CHILD; CHROMOSOME 16P; CHROMOSOME 17P; CHROMOSOME 6; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DIPLOIDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOSS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MEDICAL EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMALL CELL OSTEOSARCOMA; STRUCTURAL HOMOLOGY; TISSUE SECTION;

BONE NEOPLASMS; CHILD; CHROMOSOME BANDING; CHROMOSOMES, HUMAN, 16-18; CHROMOSOMES, HUMAN, PAIR 6; GENE DELETION; GENES, P53; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MALE; OSTEOSARCOMA; PROTO-ONCOGENE PROTEINS C-BCL-2; TIBIA; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 33744729027     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-006-0181-x     Document Type: Article

References (28)

1. Baron BW, Anastasi J, Thirman MJ, Furukawa Y, Fears S, Kim DC, Simone F, Birkenbach M, Montag A, Sadhu A, Zeleznik-Le N, McKeithan TW (2002) The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis. Proc Natl Acad Sci U S A 99:2860-2865
2. Biegel JA, Wormer RB, Emanuel BS (1989) Complex karyotypes in a series of pediatric osteosarcomas. Cancer Genet Cytogenet 38:89-100
3. Boehm AK, Neff JR, Squire JA, Bayani J, Nelson M, Bridge JA (2000) Cytogenetic findings in 36 osteosarcoma specimens and a review of the literature. Pediatr Pathol Mol Med 19:359-376
4. Bridge JA, Nelson M, McComb E, McGuire MH, Rosenthal H, Vergara G, Maale GE, Spanier S, Neff JR (1997) Cytogenetic findings in 73 osteosarcoma specimens and a review of the literature. Cancer Genet Cytogenet 95:74-87
5. Bridge RS Jr, Bridge JA, Neff JR, Naumann S, Althof P, Bruch LA (2004) Recurrent chromosomal imbalances and structurally abnormal breakpoints within complex karyotypes of malignant peripheral nerve sheath tumour and malignant triton tumour: a cytogenetic and molecular cytogenetic study. J Clin Pathol 57:1172-1178
6. Chandar N, Billig B, McMaster J, Novak J (1992) Inactivation of p53 gene in human and murine osteosarcoma cells. Br J Cancer 65:208-214
7. Diller L, Kassel J, Nelson CE, Gryka MA, Litwak G, Gebhardt M, Bressac B, Ozturk M, Baker SJ, Vogelstein B, Friend SH (1990) p53 functions as a cell cycle control protein in osteosarcomas. Mol Cell Biol 10:5772-5781
8. Fletcher CDM, Unni KK, Mertens F (eds) (2002) World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone. IARC Press, Lyon
9. Giovannini M, Selleri L, Biegel JA, Scotlandi K, Emanuel BS, Evans GA (1992) Interphase cytogenetics for the detection of the t(11;22)(q24;q12) in small round cell tumors. J Clin Invest 90:1911-1918
10. Henriksen J, Aagesen TH, Maelandsmo GM, Lothe RA, Myklebost O, Forus A (2003) Amplification and overexpression of COPS3 in osteosarcomas potentially target TP53 for proteasome-mediated degradation. Oncogene 22:5358-5361
11. Higashino F, Yoshida K, Noumi T, Seiki M, Fujinaga K (1995) Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters. Oncogene 10:1461-1463
12. ISCN (2005) An international system for human cytogenetic nomenclature. In: Shaffer LG, Tommerup N (eds) Karger, Basel
13. Knuutila S, Bjorkqvist A-M, Autio K, Tarkkanen M, Wolf M, Monni O, Szymanska J, Larramendy ML, Tapper J, Pere H, El-Rifai W, Hemmer S, Wasenius V-M, Vidgren V, Zhu Y (1998) DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol 152:1107-1123
14. Ladanyi M, Gorlick R (2000) Molecular pathology and molecular pharmacology of osteosarcoma. Pediatr Pathol Mol Med 19:391-413
15. Lonardo F, Ueda T, Huvos AG, Healy J, Ladanyi M (1997) p53 and MDM2 alterations in osteosarcoma: correlation with clinicopathologic features and proliferative rate. Cancer 79:1541-1547
16. Nakajima H, Sim FH, Bond J, Unni KK (1997) Small cell osteosarcoma of bone. Cancer 79:2095-2106
17. Naumann S, Krallman PA, Unni KK, Fidler ME, Neff JR, Bridge JA (2002) Translocation der(13;21)(q10;q10) in skeletal and extraskeletal mesenchymal chondrosarcoma. Mod Pathol 15:572-576
18. Noguera R, Navarro S, Triche TJ (1990) Translocation (11;22) in small cell osteosarcoma. Cancer Genet Cytogenet 45:121-124
19. Papai Z, Feja CN, Hanna EN, Sztan M, Olah E, Szendroi M (1997) P53 overexpression as an indicator of overall survival and response to treatment in osteosarcomas. Pathol Oncol Res 3:15-19
20. Prasad R, Gu Y, Alder H, Nakamura T, Canaani O, Saito H, Huebner K, Gale RP, Nowell PC, Kuriyama K (1993) Cloning of the ALL-1 fusion partner, the AF-6 gene, involved in acute myeloid leukemias with the t(6;11) chromosome translocation. Cancer Res 53:5624-5628
21. Sandberg AA, Bridge JA (2003) Updates on cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors. Cancer Genet Cytogenet 145:1-30
22. Sim FH, Unni KK, Beabout JW, Dahlin DC (1979) Osteosarcoma with small cells simulating Ewing's tumor. J Bone Joint Surg Am 61:207-215
23. Sjogren H, Orndal C, Tingby O, Meis-Kindblom JM, Kindblom L-G, Stenma G (2004) Cytogenetic and spectral karyotype analyses of benign and malignant cartilage tumours. Int J Oncol 24:1385-1391
24. Sztan M, Papai Z, van der Looij M, Olah E (1997) Allelic losses from chromosome 17 in human osteosarcomas. Pathol Oncol Res 3:115-120
25. Tomasetto C, Regnier C, Moog-Lutz C, Mattei MG, Chenard MP, Lidereau R, Basset P, Rio MC (1995) Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11-q21.3 region of chromosome 17. Genomics 28:367-376
26. Tsuchiya T, Sekine K, Hinohara S, Namiki T, Nobori T, Kaneko Y (2000) Analysis of the p16INK4, p14ARF, p15, TP53, and MDM2 genes and their prognostic implications in osteosarcoma and Ewing sarcoma. Cancer Genet Cytogenet 120:91-98
27. van Dartel M, Hulsebos TJM (2004) Amplification and overexpression of genes in 17p11.2-p12 in osteosarcoma. Cancer Genet Cytogenet 153:77-80
28. Yotov WV, Hamel H, Rivard G-E, Champagne MA, Russo PA, Leclerc J-M, Bernstein ML, Levy E (1999) Amplifications of DNA Primase 1 (PRIM1) in human osteosarcoma. Genes Chromosomes Cancer 26:62-69